Aetna and Horizon Blue Cross Blue Shield of New Jersey must comply with subpoenas seeking their employees’ testimony for a lawsuit accusing Mylan NV of engaging in a scheme to squelch competition for its EpiPen allergy treatment, a federal magistrate judge has ruled.
US Magistrate Judge Teresa James in Kansas City, Kansas, on Monday, November 19, rejected the insurers’ arguments that the subpoenas from lawyers for a proposed class of consumers were unduly burdensome and sought information that could already be found in records they turned over.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
